Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

141. Sleep disorders in children and young people with attention deficit hyperactivity disorder: melatonin

, Starreveld JS et al. (2003) Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study. European Journal of Pediatrics 162: 554–5 van der Heijden KB, Smits MG, Someren EJ et al. (2007) Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. Journal of the American Academy of Child and Adolescent Psychiatry 46: 233–41 Waldron D, Bramble D, Gringas P (2005) Melatonin: prescribing practices (...) , characterised by poor quality of sleep, in adults who are aged 55 years or over. Additional melatonin products are available from special-order manufacturers or specialist importing companies, or can be purchased directly online. No high-quality studies were identified that provided evidence for the efficacy of prolonged- release melatonin tablets (licensed in the UK) used off-label in children with sleep disorders and attention deficit hyperactivity disorder (ADHD). Limited evidence for unlicensed

2013 National Institute for Health and Clinical Excellence - Advice

142. The Family-School Success intervention improves some family and educational outcomes in children with attention deficit hyperactivity disorder more than a control psychosocial intervention

for children with attention deficit hyperactivity disorder (ADHD) and their families effective in improving family and educational functioning? Patients: 199 school children in grades 2–6 with DSM-IV ADHD and their families. Setting: One paediatric hospital's ADHD centre, USA. Intervention: The FSS intervention versus the Coping with ADHD through Relationships and Education (CARE) intervention over 12 weeks. The weekly FSS sessions consisted of: six parent group meetings and simultaneous child group (...) The Family-School Success intervention improves some family and educational outcomes in children with attention deficit hyperactivity disorder more than a control psychosocial intervention The Family-School Success intervention improves some family and educational outcomes in children with attention deficit hyperactivity disorder more than a control psychosocial intervention | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you

2013 Evidence-Based Mental Health

143. Review: little evidence that PUFA supplementation improves symptoms in ADHD

effective are polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents? Outcomes: Primary outcome: change in ADHD symptoms using validated scales. Secondary outcomes: behavioural problems, anxiety symptoms, depressive symptoms, quality of life, adverse effects, cost and loss to follow-up. Methods Design: Systematic review and meta-analysis. Data sources: CENTRAL (The Cochrane Library 2011, Issue 2), MEDLINE (1948 to July Week 3, 2011), EMBASE (...) Review: little evidence that PUFA supplementation improves symptoms in ADHD Review: little evidence that PUFA supplementation improves symptoms in ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts

2013 Evidence-Based Mental Health

144. Boys with ADHD are at increased risk of psychosocial, educational and functional impairment in adulthood

with ADHD are at increased risk of psychosocial, educational and functional impairment in adulthood Statistics from Altmetric.com Question Question: What is the burden of psychosocial and functional impairments in adulthood which are associated with attention deficit/hyperactivity disorder (ADHD) in youth? Population: 260 Caucasian boys of ages 6–17 years (140 with DSM-III-R clinician-ascertained ADHD, and 120 without the condition). Those with psychosis, autism, inadequate command of the English (...) language or an IQ of less than 80 were excluded. From this original sample, 79 (56%) of those with ADHD and 90 (75%) of those without the condition took part in a 16 year follow-up. Setting: USA; 1988–2006. Prognostic factors: ADHD during youth. Outcomes: Mood and anxiety disorders (major depressive disorder, bipolar disorder, anxiety disorders, agoraphobia, social phobia, obsessive-compulsive disorder, specific phobia, panic disorder and generalised anxiety disorder); antisocial and substance

2013 Evidence-Based Mental Health

145. Review: childhood ADHD does not appear to predict development of bipolar disorder among children of bipolar parents

: childhood ADHD does not appear to predict development of bipolar disorder among children of bipolar parents Statistics from Altmetric.com Question Question: Is there an association between childhood attention deficit hyperactivity disorder (ADHD) and development of bipolar disorder among children of parents with confirmed bipolar disorder? Outcomes: Diagnostic and statistical manual diagnoses. The main outcomes of interest were ADHD and bipolar disorder. Methods Design: Systematic review. Data sources (...) Review: childhood ADHD does not appear to predict development of bipolar disorder among children of bipolar parents Review: childhood ADHD does not appear to predict development of bipolar disorder among children of bipolar parents | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your

2013 Evidence-Based Mental Health

146. Artificial food colour exclusion and free fatty acid supplementation may reduce symptom severity in children with ADHD

Artificial food colour exclusion and free fatty acid supplementation may reduce symptom severity in children with ADHD Statistics from Altmetric.com Question Question: Are dietary and pharmacological interventions effective for the treatment of attention deficit hyperactivity disorder (ADHD)? Outcomes: Post-treatment change from baseline in total ADHD symptom severity as measured by ADHD-specific symptom scales (eg, the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) ADHD (...) Artificial food colour exclusion and free fatty acid supplementation may reduce symptom severity in children with ADHD Artificial food colour exclusion and free fatty acid supplementation may reduce symptom severity in children with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your

2013 Evidence-Based Mental Health

147. Clinical and functional outcomes worse in adults diagnosed with ADHD as children

Question: What is effect of childhood attention-deficit/hyperactivity disorder (ADHD) on adult clinical and functional outcomes? Population: Probands: 207 boys (mean age 8 years; range 6–12 years) referred to the medical centre by teachers due to behavioural problems. Only children with hyperactive/impulsive disorder were included; children with aggressive or antisocial behaviour were excluded. Comparators: When probands were aged 18 years (average), men also aged 18 who had attended the medical centre (...) for non-psychiatric reasons between the ages of 6 and 12 were identified. In total, 178 met the inclusion criteria of no symptoms due to behaviour from primary school teachers (parent report). Setting: Medical centre, New York; proband recruitment 1970–1978. Prognostic factors: Diagnosis of ADHD in childhood. Clinical notes were examined and a subsequent confirmatory diagnosis of ADHD was made by comparing with Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria

2013 Evidence-Based Mental Health

148. ADHD symptom severity and diagnosis remains relatively stable over 6-year period following diagnosis in preschool

and diagnosis remains relatively stable over 6-year period following diagnosis in preschool Statistics from Altmetric.com Question Question: What is the trajectory of symptom severity and diagnosis of attention-deficit hyperactivity disorder (ADHD) among children of 6 years after diagnosis during preschool? Population: A total of 207 children (75% male) diagnosed with moderate-to-severe ADHD at ages 3–5 years identified from the original Preschool ADHD Treatment Study (PATS). Mean age was 4.4 years (...) ADHD symptom severity and diagnosis remains relatively stable over 6-year period following diagnosis in preschool ADHD symptom severity and diagnosis remains relatively stable over 6-year period following diagnosis in preschool | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username

2013 Evidence-Based Mental Health

149. Cogmed Working Memory Training for youth with ADHD: a closer examination of efficacy utilizing evidence-based criteria Full Text available with Trip Pro

be effective for children and adolescents with attention deficit hyperactivity disorder (ADHD). Despite some review limitations, the authors’ conclusions and recommendations for research seem appropriate and are likely to be reliable. Authors' objectives To determine the short and long-term effectiveness of Cogmed Working Memory Training (CWMT) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Searching PsycINFO, PubMed, and the CWMT website were searched for peer-reviewed (...) A, Feirsen N, Bedard AC, Marks D, Uderman JZ, Chimiklis A. Cogmed Working Memory Training for youth with ADHD: a closer examination of efficacy utilizing evidence-based criteria. Journal of Clinical Child and Adolescent Psychology 2013; 42(6): 769-783 PubMedID DOI Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Attention Deficit Disorder with Hyperactivity /physiopathology /therapy; Child; Cognitive Therapy; Evidence-Based Medicine; Humans; Memory, Short-Term /physiology; Randomized

2013 DARE.

150. Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology Full Text available with Trip Pro

, the limited number of trials, and the validity of the statistical analysis, mean that these results should be interpreted with caution. Authors' objectives To compare the efficacy of guanfacine extended release versus atomoxetine, for the treatment of attention deficit hyperactivity disorder (ADHD), in children and adolescents. Searching Five databases, including MEDLINE and Cochrane Central Register of Controlled Trials (CENTRAL), were searched in December, 2012, for primary studies published in English (...) Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology Comparative efficacy of guanfacine extended release

2013 DARE.

151. Methylphenidate reduces ADHD symptoms in children with severe ADHD and intellectual disability

and intellectual disability Statistics from Altmetric.com Question Question: Are stimulants safe and effective for the treatment of children with attention deficit hyperactivity disorder (ADHD) and intellectual disability? Patients: 122 children and adolescents (aged 7 years; 85% male) with ADHD (International Classification of Disease-10 diagnosis of hyperkinetic disorder) and intellectual disability (IQ 30–69). Recruitment was through clinical referrals and community screening (using the Special Education (...) Methylphenidate reduces ADHD symptoms in children with severe ADHD and intellectual disability Methylphenidate reduces ADHD symptoms in children with severe ADHD and intellectual disability | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts

2013 Evidence-Based Mental Health

152. Exposure to intimate partner violence and parental depression increases risk of ADHD in preschool children Full Text available with Trip Pro

Exposure to intimate partner violence and parental depression increases risk of ADHD in preschool children Exposure to intimate partner violence and parental depression increases risk of ADHD in preschool children | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Exposure to intimate partner violence and parental depression increases risk of ADHD in preschool children Article Text Children & Adolescents Exposure to intimate partner violence

2013 Evidence-Based Mental Health

153. [Indirect comparison methodology research for health technology assessment: Comparison of drug treatment effect in adult attention deficit hyperactivity disorder using a common comparator]

disorder using a common comparator] Seoul: National Evidence-based Healthcare Collaborating Agency (NECA). NECA-A-13-005. 2013 Authors' conclusions In this research, an indirect comparison methodology used in the context of Health Technology Assessment (HTA). As an example of HTA using indirect comparison, the efficacy of Atomoxetine and Methylphenidate in Adults Attention Deficit Hyperactivity Disorder(ADHD): A Rapid Review conducted by full term for NECA in 2012 was selected as an exemplar. Indirect (...) [Indirect comparison methodology research for health technology assessment: Comparison of drug treatment effect in adult attention deficit hyperactivity disorder using a common comparator] [Indirect comparison methodology research for health technology assessment: Comparison of drug treatment effect in adult attention deficit hyperactivity disorder using a common comparator] [Indirect comparison methodology research for health technology assessment: Comparison of drug treatment effect in adult

2013 Health Technology Assessment (HTA) Database.

154. Systematic reviews on aspects of diagnosis and treatment of attention deficit disorder Full Text available with Trip Pro

Systematic reviews on aspects of diagnosis and treatment of attention deficit disorder Revisiones sistem�ticas en aspectos de diagn�stico y tratamiento del s�ndrome de d�ficit atencional - Medwave Revista Biom�dica Revisada Por Pares | | | | | Email: Clave: Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Para poder enviarle a su direcci�n de correo electr�nico su contrase�a, es necesario que ingrese su e-mail. Email: Editorial Medwave 2012 Sep;12(8):e5478 doi (...) : 10.5867/medwave.2012.08.5478 Revisiones sistem�ticas en aspectos de diagn�stico y tratamiento del s�ndrome de d�ficit atencional Systematic reviews on aspects of diagnosis and treatment of attention deficit disorder Fernando Novoa | Para Descargar PDF debe Abrir sesi�n. | | En esta nueva edición Medwave ofrece al lector revisiones sistemáticas* sobre los aspectos más relevantes del síndrome de déficit atencional. Este es un significativo aporte sobre la patología neuropsiquiátrica más frecuente del

2012 Medwave

155. Conners’ and intelligence scales in the diagnosis of attention deficit disorder in population between 6 and 19 years: a systematic review Full Text available with Trip Pro

del art�culo y al medio en que se publica, en este caso, Medwave. Introduction: DSM-IV criteria are generally used to diagnose Attention Deficit and Hyperactivity Disorder (ADHD); however, this is complex and can be expensive. Consequently, several specific scales or behavioral (psycho-neurological tests) tests have been introduced, which leads to the need of knowing about their usefulness in ADHD. Purpose: To identify, synthesize and evaluate the best available evidence on the usefulness (...) hyperactivity disorder. Pediatr Neurol. 2007 Jun;36(6):373-81. | | | Oie M, Rund BR. Neuropsychological deficits in adolescent-on set schizophrenia compared with attention deficit hyperactivity disorder. Am J Psychiatry. 1999 Aug;156(8):1216-22. | | | Wodka EL, Loftis C, Mostofsky SH, Prahme C, Larson JC, Denckla MB, et al. Prediction of ADHD in boys and girls using the D-KEFS. Arch Clin Neuropsychol. 2008 May;23(3):283-93. Epub 2008 Feb 19. | | | | Institute for Clinical Systems Improvement. Diagnosis

2012 Medwave

156. Effectiveness and safety of methylphenidate for ADHD in population between 6 and 19 years: a systematic review Full Text available with Trip Pro

-mail. Email: Revisi�n sistem�tica Medwave 2012 Sep;12(8):e5472 doi: 10.5867/medwave.2012.08.5472 Evaluaci�n de la efectividad y seguridad del metilfenidato para d�ficit atencional en poblaci�n entre 6 y 19 a�os: revisi�n sistem�tica Effectiveness and safety of methylphenidate for ADHD in population between 6 and 19 years: a systematic review Jos� Calleja, Jos� Uribarri | | Para Descargar PDF debe Abrir sesi�n. | | Palabras clave: attention deficit disorder with hyperactivity, methylphenidate (...) Atribuci�n-NoComercial 3.0 Unported. Esta licencia permite el uso, distribuci�n y reproducci�n del art�culo en cualquier medio, siempre y cuando se otorgue el cr�dito correspondiente al autor del art�culo y al medio en que se publica, en este caso, Medwave. Introduction: Attention deficit hyperactivity disorder (ADHD) is generally treated with pharmacologic and non-pharmacologic interventions. Methylphenidate is the most widely used drug and is available to most patients. Purpose: To identify

2012 Medwave

157. Effectiveness and safety of long-acting versus short acting methylphenidate in ADHD in population between 6 and 19 years: a systematic review Full Text available with Trip Pro

del art�culo y al medio en que se publica, en este caso, Medwave. Introduction: Attention deficit hyperactivity disorder (ADHD) is generally treated with short-acting methylphenidate, but recently a long-acting presentation has been introduced, hence the interest of the study to evaluate the two formulations. Purpse: To identify, synthesize and evaluate the best available evidence on the effectiveness and safety of long-acting methylphenidate versus short-acting treatment for ADHD in the 6-19 year (...) and adolescents. Bloomington: Institute for Clinical Systems Improvement, 2010:72. | | Scottish Intercollegiate Guidelines Network. Management of attention deficit and hyperkinetic disorders in children and young people. A national clinical guideline. Edinburgh,Scotland: Scottish Intercollegiate Guidelines Network (SIGN), 2009:52. | | National Collaborating Centre for Mental Health. Attention deficit hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. London

2012 Medwave

158. EEG, CT scan and MRI as diagnostic tools for ADHD in population between 6 and 19 years: a systematic review Full Text available with Trip Pro

publicado. Los formularios pueden ser solicitados contactando al autor responsable. Esta obra de Medwave est� bajo una licencia Creative Commons Atribuci�n-NoComercial 3.0 Unported. Esta licencia permite el uso, distribuci�n y reproducci�n del art�culo en cualquier medio, siempre y cuando se otorgue el cr�dito correspondiente al autor del art�culo y al medio en que se publica, en este caso, Medwave. Introduction: Attention deficit and hyperactivity disorder (ADHD) is generally diagnosed based (...) of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol. 2006 Oct;23(5):440-55. | | | Green M, Wong M, Atkins D, Taylor J, Feinleib M. Diagnosis of Attention-Deficit/Hyperactivity Disorder. Technical Review No.3. Rockville US: Agency for Health Care Policy and Research, 1999. Snyder SM, Quintana H, Sexson SB, Knott P, Haque AF, Reynolds DA. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res

2012 Medwave

159. Effectiveness and safety of antidepressants for ADHD in population between 6 and 19 years: a systematic review Full Text available with Trip Pro

e-mail. Email: Revisi�n sistem�tica Medwave 2012 Sep;12(8):e5474 doi: 10.5867/medwave.2012.08.5474 Evaluaci�n de la efectividad y seguridad de los antidepresivos para d�ficit atencional en poblaci�n entre 6 y 19 a�os: revisi�n sistem�tica Effectiveness and safety of antidepressants for ADHD in population between 6 and 19 years: a systematic review Jos� Calleja, Jos� Uribarri | | Para Descargar PDF debe Abrir sesi�n. | | Palabras clave: attention deficit disorder with hyperactivity (...) , Asseburg C, Richardson G, et al. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technology Assessment. 2006;10(23):382. | | | Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc

2012 Medwave

160. Conners’ and intelligence scales in the diagnosis of attention deficit disorder in population between 6 and 19 years: a systematic review Full Text available with Trip Pro

del art�culo y al medio en que se publica, en este caso, Medwave. Introduction: DSM-IV criteria are generally used to diagnose Attention Deficit and Hyperactivity Disorder (ADHD); however, this is complex and can be expensive. Consequently, several specific scales or behavioral (psycho-neurological tests) tests have been introduced, which leads to the need of knowing about their usefulness in ADHD. Purpose: To identify, synthesize and evaluate the best available evidence on the usefulness (...) hyperactivity disorder. Pediatr Neurol. 2007 Jun;36(6):373-81. | | | Oie M, Rund BR. Neuropsychological deficits in adolescent-on set schizophrenia compared with attention deficit hyperactivity disorder. Am J Psychiatry. 1999 Aug;156(8):1216-22. | | | Wodka EL, Loftis C, Mostofsky SH, Prahme C, Larson JC, Denckla MB, et al. Prediction of ADHD in boys and girls using the D-KEFS. Arch Clin Neuropsychol. 2008 May;23(3):283-93. Epub 2008 Feb 19. | | | | Institute for Clinical Systems Improvement. Diagnosis

2012 Medwave